NCT00936442 - Arimidex Therapy Compliance Electronic Monitoring System | Biotech Hunter

Enrollment

104

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2010

Conditions

Breast Cancer

Interventions

DRUG

Anastrozole

(Standard Treatment) 12-month follow-up of anastrozole treatment according to SmPC and current clinical practice.

OTHER

Educational materials

Reception of educational material on regular basis.

Trial Locations (4)

Research Site, Brussels

Research Site, Leuven

Research Site, Liège

Research Site, Overpelt